Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Cyclically Adjusted PB Ratio: (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600479 Zhuzhou Qianjin Pharmaceutical Co Ltd SHSE:600479
70 GF Score
Price ¥11.02
GF Value ¥9.45
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Zhuzhou Qianjin Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhuzhou Qianjin Pharmaceutical Co  (SHSE:600479) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zhuzhou Qianjin Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Zhuzhou Qianjin Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Zhuzhou Qianjin Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhuzhou Qianjin Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Zhuzhou Qianjin Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.92 2.11 2.26 2.14 1.95

Zhuzhou Qianjin Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 2.00 1.95 2.04 0.00

SHSE:600479 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhuzhou Qianjin Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhuzhou Qianjin Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhuzhou Qianjin Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhuzhou Qianjin Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600479
70GF Score
Zhuzhou Qianjin Pharmaceutical Co Ltd SHSE:600479
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhuzhou Qianjin Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zhuzhou Qianjin Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Zhuzhou Qianjin Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=6.139/116.0564*116.0564
=6.139

Current CPI (Jun. 2026) = 116.0564.

Zhuzhou Qianjin Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 3.972 102.400 4.502
201612 4.171 102.600 4.718
201703 4.238 103.200 4.766
201706 4.116 103.100 4.633
201709 4.241 104.100 4.728
201712 4.486 104.500 4.982
201803 4.567 105.300 5.034
201806 4.400 104.900 4.868
201809 4.576 106.600 4.982
201812 4.901 106.500 5.341
201903 5.009 107.700 5.398
201906 4.704 107.700 5.069
201909 4.885 109.800 5.163
201912 5.204 111.200 5.431
202003 5.295 112.300 5.472
202006 4.897 110.400 5.148
202009 5.095 111.700 5.294
202012 5.416 111.500 5.637
202103 5.507 112.662 5.673
202106 4.664 111.769 4.843
202109 4.868 112.215 5.035
202112 5.138 113.108 5.272
202203 5.096 114.335 5.173
202206 4.706 114.558 4.768
202209 4.888 115.339 4.918
202212 5.158 115.116 5.200
202303 5.271 115.116 5.314
202306 5.108 114.558 5.175
202309 5.306 115.339 5.339
202312 5.571 114.781 5.633
202403 5.749 115.227 5.790
202406 5.572 114.781 5.634
202409 5.690 115.785 5.703
202412 5.807 114.893 5.866
202503 5.937 115.116 5.986
202506 5.759 114.907 5.817
202509 5.082 115.471 5.108
202512 6.152 115.832 6.164
202603 6.305 116.303 6.292
202606 6.139 116.056 6.139

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Zhuzhou Qianjin Pharmaceutical Co (SHSE:600479) Overvalued in 2026?

Based on GuruFocus' analysis, Zhuzhou Qianjin Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥11.02 is trading 16.6% above its estimated GF Value™ of ¥9.45. GuruFocus considers Zhuzhou Qianjin Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600479:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ¥9.45 vs. price of ¥11.02 (16.6% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600479 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhuzhou Qianjin Pharmaceutical Co Business Description

Address No. 801, Zhuzhou Avenue, Tianyuan District, Hunan Province, Zhuzhou, CHN, 412000
Zhuzhou Qianjin Pharmaceutical Co Ltd is engaged in Chinese medicine, chemical medicine, and health supplies businesses in China. It produces medicines in the form of tablets, granules, and hard capsules. The company's products include Gynecological Qianjin Tablets (Capsules), Blood-Boosting Yimu Pills (Granules), Valsartan Capsules, Enalapril Maleate Tablets, Difenidol Hydrochloride Tablets, Silybin Meglumine Tablets, Entecavir Dispersible Tablets, Gynecological Special Cotton Towel Series, etc.
70GF Score

Get the complete analysis for SHSE:600479

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.02
Price
¥9.45
GF Value